The Medtronic Resting Heart System (RHS) is a heparin-coated, closed perfusion circuit. Clinical results indicate less haemodilution and reduced complement activation, when compared with a traditional circuit leading to fewer postoperative blood transfusions. We evaluated the potential clinical benefits, including reduced transfusion requirements, when using the RHS compared with conventional cardiopulmonary bypass (cCPB). The study group (n = 330) consisted of patients undergoing isolated coronary artery bypass grafting (CABG) using the RHS system during 2005-2009, matched with a control group (n = 609) including patients operated for isolated CABG during 2002-2009, utilizing cCPB. Significantly fewer patients received peri-and postoperative blood transfusions in the RHS group (25 vs. 37%, P < 0.001; mean 1.0 ± 2.6 vs. mean 1.6 ± 2.9 units of packed red blood cells). The incidence of reoperations due to bleeding was low, RHS 2% (n = 8) vs. cCPB 5% (n = 29), with a trend towards no significant difference between groups (P = 0.079). The duration of mechanical ventilation was shorter (mean 7 ± 16 vs. 9 ± 12 h, P < 0.001) for patients in the RHS group. This study demonstrates that CABG performed with the RHS reduces the incidence and magnitude of allogenic blood transfusion and results in a satisfactory clinical outcome.
INTRODUCTION
Conventional cardiopulmonary bypass (cCPB) is the state-of-the-art perfusion technique for on-pump coronary artery bypass grafting (CABG) [1] . Nevertheless, morbidity associated with conventional extracorporeal technologies remains significant [2] , due mainly to stimulation of global inflammatory response [3] and induction of coagulation disorders [4] , potentially increasing the risk of excessive postoperative bleeding. In addition, the risk of postoperative bleeding has been accentuated with the highly potent anticoagulant treatment currently applied with unstable angina [5] , necessitating transfusion of blood products. The use of allogenic blood transfusions, in turn, has shown to be independently associated with an increased frequency of organ dysfunction or failure and long-term morbidity and mortality following cardiac surgery [6] . At present, 60-70% of the patients undergoing CABG at our department receive allogenic blood transfusions and the incidence of reoperation due to excessive postoperative bleeding remains high (4-6%). Therefore, interventions aimed at reducing bleeding and rate of blood transfusions are highly demanded.
To minimize CPB-related complications, several minimally invasive CPB systems have been evaluated in the clinical setting as promising alternatives to cCPB. These systems are closed circuits with biocompatible surfaces, require reduced priming volume and separate the pericardial shed blood suction with the potential to address many of the problems associated with the use of a cCPB system [7] and various advantages that have previously been reported [7] . On a practical basis, minimally invasive systems require a specific expertise, have a prolonged learning curve and are more expensive than conventional circuits, in addition to some concerns raised with respect to their safety [8, 9] . Therefore, their use is justified only if their positive impact on postoperative outcome is well proven. In the present study, we analysed the potential benefits of a commercially available minimally invasive system (the RHS) and compared the results with those of cCPB in patients undergoing isolated CABG.
METHODS

Patient population
The study protocol was approved by the Ethics Committee for Clinical Research at Lund University, Sweden. Between January 2002 and May 2009, 6302 consecutive patients underwent primary isolated CABG surgery at the Department of Cardiothoracic Surgery at Skane University Hospital, Lund, Sweden. Patients undergoing CABG with the RHS (n = 330) were prospectively enrolled between October 2005 and May 2009. These patients were matched with 609 patients undergoing CABG with cCPB for age, sex and other co-morbidity as denoted by their calculated logistic EuroSCORE [10] . Patients undergoing re-operation for CABG or valve surgery were excluded from analysis. The pre-, intra-and postoperative variables were prospectively collected and entered into the department's computerized cardiac surgical database.
Extracorporeal techniques
The Resting Heart System™ (RHS; Medtronic, Inc., Minneapolis, MN, USA) is a low-prime, semi-closed-loop minimally invasive CPB system, offering minimal air-blood interface with separation of the pericardial shed blood suction, a centrifugal pump and reduction in systemic heparinization. Primary blood contact surfaces are coated with heparin (BioActive Surface, Carmeda, Stockholm, Sweden) throughout to provide thromboresistance and biocompatibility by mimicking critical characteristics of vascular endothelium. The absence of cardiotomy reservoirs limits the artificial surface-blood contact secondary to aspiration of blood. Accordingly, an erythrocyte scavenging device is necessary when using the RHS. The final priming volume of the circuit is 800 ml (excluding the tubing set and a filter, which is removed when the tubing set is connected to the arterial and venous cannulas). One of the key features of the RHS system lies in the retrograde arterial priming (RAP) procedure which allows for further reduced haemodilution. Following RAP, a further 500 ml is removed from the system, ending up with a total of 300 ml of priming volume, with the potential to influence haemodilutation. The system is equipped with an active venous air detector and removal device that detects and automatically removes venous air. After weaning, the shed blood during the operation was collected and washed in a cell saver together with the remaining blood from the RHS circuit and re-transfused to the patient. Anticoagulation was established with a target activated clotting time (ACT) of 480 s.
The conventional CPB system consisted of an open circuit with a hard-shell reservoir receiving blood from the venous cannulation, an active vent from the aortic root, and the entire surgical field suctions were directly sent to the venous reservoir. The circuit was primed with 1000 ml Ringer acetate and 250 ml mannitol solution. Anticoagulation was established with an initial heparin dose of 300-400 IU/kg of body weight before the initiation of CPB and with a target ACT of 480 s.
At the end of CPB, for both groups, heparin was reversed by protamine sulphate at a 1:1 or 1:1.5 ratio of the loading dose, regardless of the total heparin dosage. No difference between groups existed with respect to the pump flow and pressure policy (the target mean arterial pressure was adjusted between 60 and 70 mmHg) and the protamine sulphate administration protocol.
Measurement of serological markers
Serial blood samples were withdrawn and analysed at four different time points: preoperatively (D0), on the postoperative morning (D1), on postoperative day 4 (D4) and on discharge (DC). Serial intraoperative arterial blood gas measurements allowed for monitoring of haemoglobin and haematocrit levels and transfusion was triggered by a haematocrit value of <20% or haemoglobin value of <80 g/l.
Statistical analysis
The results are given with categorical data as proportions, and continuous variables are expressed as the mean ± standard deviation (SD). The χ 2 test was used for categorical variables, except when the expected frequencies were lower than five, in which case Fisher's exact test was used. The un-paired Student's t-test or Mann-Whitney U test was performed to compare continuous variables. Data were analysed using the Hmisc and Design packages of the R software (R Foundation for Statistical Computing, Vienna, Austria, version 2.9.1). The level of significance was set at P < 0.05.
RESULTS
Patients operated on with the RHS system were younger (P = 0.014) but demonstrated a higher prevalence of diabetes mellitus (P = 0.031) and preoperative renal failure (S-creatinine levels >200 µmol/l, P = 0.024). Left main stenosis was more prevalent in the cCPB group (P = 0.05). The preoperative characteristics for the two groups are shown in Table 1 .
Clinical data
Anticoagulation was established with a mean heparin dose of 32 000 ± 12 000 IU in the RHS group and 41 000 ± 13 000 IU in the cCPB group, (P < 0.001). The mean aortic cross-clamp time was 46 ± 16 min in the RHS group and 45 ± 15 min in the cCPB group. The CPB balance was mean 1250 ± 1100 ml in the RHS group and 2000 ± 1000 ml in the cCPB group, (P < 0.001). The cumulative postoperative fluid balance was mean 2100 ± 1300 ml in the RHS group and 3500 ± 1200ml in the cCBP group, (P < 0.001). Anticoagulation was reversed with Protamine administered with a mean dose of 400 ± 200 mg in the RHS group and 550 ± 150 mg in the cCPB group, (P < 0.001).
The outcome variables depicting the clinical course are presented in Table 2 . After surgery, the need for mechanical ventilation was shorter in the RHS group compared with patients who were operated on using cCPB (P < 0.001). The 30-day mortality in the cCPB group was 0.3% (n = 2) with no significant difference between groups (RHS 0%, P = 0.3). The reliability of a multivariable model analysis for predictors of mortality was compromised by the low number of deceased patients. The incidence of postoperative reoperation due to postoperative bleeding was 4%, with a trend towards significance between groups (P = 0.079). The overall red blood cell (RBC) transfusion rate was 25% (n = 83) in the RHS group, whereas 37% (n = 226) in the cCPB group received RBC transfusions, (P < 0.001). The number of units of RBC administered was significantly lower in the RHS group (1.0 ± 2.6 units) when compared with the cCPB group (1.6 ± 2.9 units), (P < 0.001), Table 3 .
Serological data
The mean preoperative haemoglobin level was similar in both groups, but the mean haemoglobin level for D1 was lower than that for the cCPB group (106 ± 13 vs. 112 ± 14 g/L, P < 0.001). At D4 and upon DC, the difference was non-significant ( Fig. 1) . Preand postoperative S-creatinine levels were in the same range with no significant difference between groups. The mean serological levels at the different time points are demonstrated in Table 4 .
DISCUSSION
The main finding of the present study was that utilization of the minimally invasive RHS for isolated CABG significantly lowered the incidence and magnitude of RBC transfusion and indicated a trend towards lower incidence of re-operation for bleeding. In addition, the postoperative course indicated an excellent end-organ protection and 30-day mortality.
Reducing transfusion requirements to diminish the low, but ever-present, risk of transfusion reactions and to save resources has been one of the driving factors for the development of minimally invasive CPB circuits [11] . The reduction in artificial surfaces for blood interaction as well as lower circuit prime volume reduces haemodilution and hold the potential to reduce the need for systemic heparin administration during CABG. In combination, these characteristics may reduce the adverse effects Several studies have previously demonstrated that blood transfusion is an independent predictor of postoperative morbidity and mortality. Every unit of RBC transfused is associated with an increased risk for an adverse outcome [12] . In the present study, utilization of the RHS was associated with a lower incidence and fewer units of RBC transfusion. There was a trend towards a lower incidence of reoperation for bleeding in the RHS group, P = 0.079. Despite the similar volume in postoperative drainage loss, the loss of haemoglobin might still be different between the two groups. As the haemoglobin level in the drainage was not measured, we cannot exclude that patients in the cCPB group had a greater loss of haemoglobin than the RHS group. In this respect, our findings are in agreement with previous reports, demonstrating that patients undergoing surgery with a minimally invasive CPB system require less allogenic blood transfusions with a reduction up to 30-50% when comparison with cCPB [13] .
The reduced RBC transfusion requirement demonstrated in the RHS group may offer a plausible explanation for the excellent Values are expressed as mean ± SD. n: number of non-missing values; ASA: aspartate aminotransferase; ALT: alanine aminotransferase; WBC: white blood count; CRP: C-reactive protein. clinical outcome in the current analysis. Patients in the RHS group were extubated earlier and discharged earlier from our cardiothoracic ward. We did not find any difference in 30-day mortality, but given that this figure was 0.3% (two patients in the cCPB group), the study may have been underpowered in this respect. Previous reports have a lower incidence of acute kidney injury after coronary revascularization with minimally invasive CPB systems in contrast to cCPB [14] . In this study, the kidney function was well preserved in both groups and the incidence of postoperative dialysis of only 0.3% was remarkably low. The evaluation of supplementary serological markers for the detection of myocardial and renal damage may add further information and prove any potential causal relationship.
The current study is limited by its non-randomized design and retrospective analysis of data from a single centre. Various factors, including surgical bias and patient selection, may influence the outcome of our patients. Therefore, conclusions are limited in their application and causality.
In conclusion, our data on the application of the RHS system in routine, isolated CABG surgery in our centre reinforce the findings from previous reports with regard to the advantages of low transfusion and reoperation rate, excellent end-organ protection and low mortality.
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Dr Nilsson: Each surgeon operating with the Resting Heart System also did an operation using conventional cardiopulmonary bypass; in other words we would have a match in the conventional group for each procedure done with the new system. I cannot say that each surgeon performed exactly an equal amount of procedures with each system, but it was the same eight senior surgeons if you put it like that. Regarding the cardiopulmonary bypass time and cross-clamp time, it was the same in both groups, there was no difference.
